Charles Schwab’s Cymabay Therapeutics CBAY Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
|
|||||
|
2023
Q4 | $20.2M | Buy |
|
|||||
|
2023
Q3 | $11.9M | Buy |
|
|||||
|
2023
Q2 | $2.9M | Buy |
|
|||||
|
2023
Q1 | $336K | Buy |
|
|||||
|
2022
Q4 | $217K | Hold |
|
|||||
|
2022
Q3 | $121K | Sell |
|
|||||
|
2022
Q2 | $144K | Sell |
|
|||||
|
2022
Q1 | $744K | Buy |
|
|||||
|
2021
Q4 | $609K | Buy |
|
|||||
|
2021
Q3 | $635K | Sell |
|
|||||
|
2021
Q2 | $2.32M | Sell |
|
|||||
|
2021
Q1 | $2.45M | Buy |
|
|||||
|
2020
Q4 | $2.98M | Sell |
|
|||||
|
2020
Q3 | $3.77M | Buy |
|
|||||
|
2020
Q2 | $1.52M | Buy |
|
|||||
|
2020
Q1 | $556K | Buy |
|
|||||
|
2019
Q4 | $725K | Sell |
|
|||||
|
2019
Q3 | $2M | Sell |
|
|||||
|
2019
Q2 | $2.81M | Buy |
|
|||||
|
2019
Q1 | $4.85M | Buy |
|
|||||
|
2018
Q4 | $2.55M | Sell |
|
|||||
|
2018
Q3 | $3.61M | Buy |
|
|||||
|
2018
Q2 | $1.75M | Buy |
|
|||||
|
2018
Q1 | $265K | Buy |
|
|||||
|
2017
Q4 | $115K | Buy |
|